2m 2m 2m 2m 2m 2m 2m
GSK Sp ADR (GSK)
NYSE
$51.87+$1.13 (+2.23%)
Price as of Jun 23, 2026 1:00 PM EDT- $101.7BMarket Cap
- 37.62%1-Year Change
- Drug Manufacturers - GeneralIndustry
GSK Sp ADR (GSK)
$51.87+$1.13 (+2.23%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 32.7B +4.11% | 31.4B +3.46% | 30.3B +3.42% | 29.3B -14.04% | |
Cost of Revenue | 9.0B -0.34% | 9.0B +5.64% | 8.6B -10.35% | 9.6B -17.66% | |
Gross Profit | 23.6B +5.92% | 22.3B +2.60% | 21.8B +10.08% | 19.8B -12.18% | |
Sales and Marketing Expense | 9.1B -17.49% | 11.0B +17.37% | 9.4B +12.10% | 8.4B -23.72% | |
Research and Development Expense | -7.5B +17.56% | -6.4B +2.86% | -6.2B +13.39% | -5.5B +3.98% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 9.1B -17.49% | 11.0B +17.37% | 9.4B +12.10% | 8.4B -23.72% | |
Operating Profit | 7.9B +97.26% | 4.0B -40.39% | 6.7B +4.85% | 6.4B +3.74% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | 0 N/A | 0 N/A | 0 +100.00% | -912.0M +17.68% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -912.0M +17.68% | |
Total Nonoperating Income and Expense | 0 N/A | 0 N/A | 0 -100.00% | 912.0M +17.68% | |
Income before Taxes | 6.3B +113.11% | 3.0B -44.40% | 5.3B -66.02% | 15.6B +206.53% | |
Income Taxes | 1.1B +111.41% | 526.0M -30.42% | 756.0M +6.93% | 707.0M +104.34% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 6.3B +113.11% | 3.0B -44.40% | 5.3B -66.02% | 15.6B +206.53% | |
Net Income from Continuing Operations Applicable to Common | 6.3B +113.11% | 3.0B -44.40% | 5.3B -66.02% | 15.6B +206.53% | |
Basic EPS and Net Income | 1.41 +123.26% | 0.63 -48.03% | 1.22 -67.26% | 3.71 +323.97% | |
Diluted EPS and Net Income | 1.39 +123.15% | 0.62 -48.12% | 1.20 -67.26% | 3.66 +322.86% | |
Basic Weighted Average Shares | 4.1B -0.64% | 4.1B +0.62% | 4.1B +0.65% | 4.0B -19.53% | |
Diluted Weighted Average Shares | 4.1B -0.64% | 4.1B +0.62% | 4.1B +0.65% | 4.0B -19.53% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.4B -12.22% | 3.9B +31.81% | 2.9B -21.14% | 3.7B -12.89% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.4B -12.22% | 3.9B +31.81% | 2.9B -21.14% | 3.7B -12.89% | |
Total Current Assets | 17.5B +3.02% | 17.0B -8.83% | 18.6B -10.23% | 20.8B +11.22% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 9.3B +1.03% | 9.2B +2.29% | 9.0B +0.97% | 8.9B -10.06% | |
Total Long-Term Assets | 43.6B +2.69% | 42.5B +5.22% | 40.4B +2.50% | 39.4B -34.84% | |
Total Assets | 61.1B +2.78% | 59.5B +0.78% | 59.0B -1.90% | 60.1B -23.96% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 3.0B +28.22% | 2.3B -16.49% | 2.8B -28.82% | 4.0B +9.75% | |
Total Current Liabilities | 21.4B -1.41% | 21.7B +2.99% | 21.1B -7.64% | 22.8B -3.63% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 23.8B -3.68% | 24.7B -1.84% | 25.1B -7.70% | 27.2B -20.10% | |
Total Liabilities | 45.2B -2.62% | 46.4B +0.36% | 46.2B -7.67% | 50.0B -13.35% | |
Retained Earnings | 10.2B +30.95% | 7.8B +7.69% | 7.2B +65.92% | 4.4B -45.08% | |
Total Stockholders Equity | 16.0B +21.93% | 13.1B +2.27% | 12.8B +26.73% | 10.1B -52.69% | |
Total Shares Outstanding | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash Flow | |||||
Cash from Operating Activities | 7.7B +18.11% | 6.6B -3.16% | 6.8B -8.58% | 7.4B -6.90% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -4.2B +244.43% | -1.2B -22.95% | -1.6B -81.82% | -8.8B +393.64% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -3.7B -22.03% | -4.7B -16.22% | -5.6B -785.42% | 823.0M +110.84% | |
Financials Ratio | |||||
Gross Margin | 72.40% +1.73% | 71.16% -0.83% | 71.76% +6.44% | 67.42% +2.17% | |
Operating Margin | 24.28% +89.47% | 12.82% -42.38% | 22.24% +1.38% | 21.94% +20.69% | |
Return on Assets | 10.43% +109.38% | 4.98% -44.08% | 8.91% -60.29% | 22.44% +251.19% | |
Return on Equity | 43.31% +89.92% | 22.80% -50.83% | 46.38% -53.33% | 99.38% +310.98% | |
Revenue Growth | 4.11% +19.07% | 3.46% +0.93% | 3.42% +124.38% | -14.04% -32,011.82% | |
Current Ratio | 0.82 +4.49% | 0.78 -11.47% | 0.88 -2.81% | 0.91 +15.41% | |
Cash Ratio | 0.16 -10.99% | 0.18 +27.98% | 0.14 -14.58% | 0.16 -9.63% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow